Valuation: Bayer AG

Market Cap 4.69TCr 5.36TCr 4.34TCr 3.98TCr 7.53TCr 5,16800Cr 7.66TCr 52TCr 20TCr 2,52400Cr 20TCr 20TCr 8,71300Cr P/E 2026 *
20.6x
P/E 2027 * 15.4x
Enterprise Value 7.87TCr 9.01TCr 7.28TCr 6.68TCr 13TCr 8,67800Cr 13TCr 87TCr 34TCr 4,23800Cr 34TCr 33TCr 14,63100Cr EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.62x
Free-Float
100%
Yield 2026 *
0.48%
Yield 2027 * 1.32%
1 week-5.00%
Current month+1.67%
1 month+35.32%
3 months+17.52%
6 months+18.27%
Current year+34.42%
1 week 206.9
Extreme 206.9
223.1
1 month 157.05
Extreme 157.05
230.5
3 years 78.97
Extreme 78.97
241
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.71%-5.00%+76.78%-9.49% 5.36TCr
+1.08%-3.93%+48.03%+160.13% 1,04300Cr
+1.19%-3.52%+51.70%+56.36% 60TCr
+4.21%+1.79%+33.48%+87.04% 45TCr
+0.18%-1.28%+29.30%+23.90% 33TCr
+0.80%0.00%+33.15%+46.35% 28TCr
-0.36%-1.84%+22.17%+23.51% 26TCr
+3.70%+2.19%+24.27%+63.38% 20TCr
+3.49%+1.08%+24.08%+76.58% 17TCr
+1.29%+3.67%+2.15%-30.78% 14TCr
Average +1.44%-0.68%+34.51%+49.70% 38.63TCr
Weighted average by Cap. +1.57%-1.82%+38.04%+81.48%

Financials

2026 *2027 *
Net sales 4.56TCr 5.22TCr 4.22TCr 3.87TCr 7.32TCr 5,02700Cr 7.45TCr 50TCr 20TCr 2,45500Cr 20TCr 19TCr 8,47600Cr 4.68TCr 5.35TCr 4.32TCr 3.97TCr 7.51TCr 5,15400Cr 7.64TCr 52TCr 20TCr 2,51700Cr 20TCr 20TCr 8,69000Cr
Net income 212.62Cr 243.25Cr 196.63Cr 180.44Cr 341.5Cr 23TCr 347.43Cr 2.35TCr 921.2Cr 11TCr 913.49Cr 893.42Cr 40TCr 293.26Cr 335.5Cr 271.2Cr 248.86Cr 471.01Cr 32TCr 479.19Cr 3.23TCr 1.27TCr 16TCr 1.26TCr 1.23TCr 55TCr
Net Debt 3.18TCr 3.64TCr 2.94TCr 2.7TCr 5.11TCr 3,51000Cr 5.2TCr 35TCr 14TCr 1,71400Cr 14TCr 13TCr 5,91800Cr 2.87TCr 3.28TCr 2.66TCr 2.44TCr 4.61TCr 3,16500Cr 4.69TCr 32TCr 12TCr 1,54600Cr 12TCr 12TCr 5,33600Cr
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
16/26/16 PLN 206.90 -1.71%
15/26/15 PLN 210.50 -2.55%
14/26/14 PLN 216.00 0.00%
13/26/13 PLN 216.00 -0.83%
10/26/10 PLN 217.80 0.00%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.72EUR
Average target price
54.92EUR
Spread / Average Target
+15.08%

Quarterly revenue - Rate of surprise